HKEX: 9906 - Honliv Healthcare Management Group Company Limited

Yield per half year: -22.11%
Dividend yield: 0.00%
Sector: Healthcare

Honliv Healthcare Management Group Company Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
37.06 35.42 4.63% 37.83 -2.05%
P/S 1.87 7.22 -74.14%
P/BV 2.59 3.7 -29.93%
P/FCF 572.73 52.22 996.75%
Ev/Ebitda 8.96 2.91 208.13%
Ev/S 1.36 19.3 -92.96%
Ev/FCF 518.18 60.19 760.91%
E/P 0.0335 0.0326 2.7%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
16.25 -9.58 -269.72% 15.74 +3.22%
ROE 7.46 5.2 43.59%
ROA 4.27 3.48 22.75%
ROIC 0 0 0%
ROS 5.03 -11.09 -145.35%
ROCE 0 0.2627 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.05 0.7714 36.11% 1.41 -25.53%
Nеt Debt/Ebitda 0 0.0387 -100%
Debt/Ratio 0.134 0.124 8.02%
Debt/Equity 0.3955 0.8079 -51.04%
Debt/Net Income 3.39 1.63 108.43%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 5.7 -100% 0 0%
Number of years of dividend growth 0 1.13 -100%
DSI 0 0.5838 -100%
Average dividend growth 0 3.2 -100%
Average percentage for 5 years 0 4.95 -100%
Average percentage for payments 69.56 23.96 190.33%
Difference from average difference in sector -5.7

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
51.8 -38.13 -235.85%
Growth impulse Ebitda in 5 years -17.36 -43.89 -60.45%
Growth impulse Net Income in 5 years -17.75 -17.26 2.84%
Growth impulse FCF in 5 years -89.67 -65.24 37.45%
Growth impulse EPS in 5 years 643.96 -99.88 -744.73%
IP Score
4.2/10

Similar companies

Zai Lab Limited

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription